Mental Health
From the Journals
CRP levels could predict SSRI success
SSRIs were less effective in depressed patients with high C-reactive protein levels than in those with low levels.
From the Journals
A ‘setback’ for anti-inflammatory treatment in depression
Study results showed minocycline was well tolerated but was not superior to placebo in reducing depressive symptoms.
Latest News
USPSTF recommends anxiety screening in adults younger than 65
Anxiety disorders are common and often go unrecognized in primary care, leading to long delays in treatment, the task force writes.
Latest News
Eighty percent of U.S. maternal deaths are preventable: Study
“It’s significant. It’s staggering. It’s heartbreaking.”
From the Journals
Ketamine linked to reduced suicidal thoughts, depression, anxiety
Sex, age, and other demographic characteristics did not predict response or remission, but suicide planning trended toward higher response rates...
Feature
How to identify and treat patients with substance use disorders
Doctors aren’t necessarily rewarded for the time it takes to develop a rapport with patients ... that leads to asking, “How much are you drinking...
Feature
Are mass shootings contagious?
“The more you’re exposed [to violence], the more likely you are to repeat it, just like the more you’re exposed to COVID, the more likely you are...
From the Journals
Omega-3 fatty acids and depression: Are they protective?
In the fully adjusted model, consumption of fatty acids from the omega-3 family had a protective effect against maintenance of depressive episodes...
From the Journals
‘Doomscrolling’ may be a significant driver of poor mental health
“It’s important for health care providers to be aware that problematic news consumption may be a significant driver of mental and physical ill-...
From the Journals
Stable, long-term opioid therapy safer than tapering?
The investigators compared three dosing strategies: abrupt withdrawal, gradual tapering, and continuation of the current stable dosage.
From the Journals
Psychedelic drug therapy a potential ‘breakthrough’ for alcohol dependence
The effects observed with psilocybin were “considerably larger” than those of currently approved treatments for alcohol use disorder.